Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation
Christoph Steeneck, Olaf Kinzel, Simon Anderhub, et al.
Nature Immunology
|
August 4, 2015
Single-cell transcriptome analysis reveals coordinated ectopic gene-expression patterns in medullary thymic epithelial cells
Philip Brennecke, Alejandro Reyes, Sheena Pinto, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2020
Discovery and optimization of substituted oxalamides as novel heme-displacing IDO1 inhibitors
Christoph Steeneck, Olaf Kinzel, Simon Anderhub, et al.
Nature Communications
|
August 2, 2022
Transcriptomic diversity in human medullary thymic epithelial cells
Jason A Carter, Léonie Strömich, Matthew Peacey, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 14, 2020
Discovery of highly potent heme-displacing IDO1 inhibitors based on a spirofused bicyclic scaffold
Olaf Kinzel, Christoph Steeneck, Simon Anderhub, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
August 20, 2014
Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation
Dominik Fröhlich, Wen Ping Kuo, Carsten Frühbeis, et al.
Immunity
|
June 14, 2015
Thymic B Cells Are Licensed to Present Self Antigens for Central T Cell Tolerance Induction
Tomoyoshi Yamano, Jelena Nedjic, Maria Hinterberger, et al.
The Journal of Clinical Investigation
|
March 26, 2011
Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans
Huijuan Lv, Evis Havari, Sheena Pinto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 12, 2024
A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas
Won Seog Kim, Jake Shortt, Pier Luigi Zinzani, et al.
European Journal of Immunology
|
October 21, 2025
CD16A Shedding Regulates Innate Cell Engager-Induced Serial Killing by Natural Killer Cells
Chiara Zambarda, Karolin Guldevall, Christian Breunig, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation
Christoph Steeneck, Olaf Kinzel, Simon Anderhub, et al.
Nature Immunology
|
August 4, 2015
Single-cell transcriptome analysis reveals coordinated ectopic gene-expression patterns in medullary thymic epithelial cells
Philip Brennecke, Alejandro Reyes, Sheena Pinto, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2020
Discovery and optimization of substituted oxalamides as novel heme-displacing IDO1 inhibitors
Christoph Steeneck, Olaf Kinzel, Simon Anderhub, et al.
Nature Communications
|
August 2, 2022
Transcriptomic diversity in human medullary thymic epithelial cells
Jason A Carter, Léonie Strömich, Matthew Peacey, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 14, 2020
Discovery of highly potent heme-displacing IDO1 inhibitors based on a spirofused bicyclic scaffold
Olaf Kinzel, Christoph Steeneck, Simon Anderhub, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
August 20, 2014
Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation
Dominik Fröhlich, Wen Ping Kuo, Carsten Frühbeis, et al.
Immunity
|
June 14, 2015
Thymic B Cells Are Licensed to Present Self Antigens for Central T Cell Tolerance Induction
Tomoyoshi Yamano, Jelena Nedjic, Maria Hinterberger, et al.
The Journal of Clinical Investigation
|
March 26, 2011
Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans
Huijuan Lv, Evis Havari, Sheena Pinto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 12, 2024
A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas
Won Seog Kim, Jake Shortt, Pier Luigi Zinzani, et al.
European Journal of Immunology
|
October 21, 2025
CD16A Shedding Regulates Innate Cell Engager-Induced Serial Killing by Natural Killer Cells
Chiara Zambarda, Karolin Guldevall, Christian Breunig, et al.
Page
of 3